ALCAlcon Inc.
Price
-17%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality mixed, nothing alarming, growing in the filings, the market undecided.
Alcon is the global leader in eye care with $10.3 billion in net sales during the year ended December 31, 2025. We research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. Based on sales for the year ended December 31, 2025, we are the number one company by global market share in the ophthalmic surgical market and in the vision care market.
In the company’s own words · 20-F filed Feb 24, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Alcon Inc. (ALC) reported revenue of $5.33B in H2 2025 (quarter ended Dec 31, 2025), up 14% from the same quarter a year earlier. That came with a gross margin of 56% and net income of $454M (8.5% of revenue). For the full year FY2025, revenue was $10.4B (+4.9% year on year) and net income $980M.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
Ranks #6 of 21 by RyuScore